Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review

BACKGROUND: Recent decades have seen combination chemoradiotherapy become the standard treatment for anal squamous cell carcinoma (SCC). However, the burden of this disease continues to rise, with only 10% of patients with metastatic disease surviving >2 years. Further insight into tumour charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Lampejo, T, Kavanagh, D, Clark, J, Goldin, R, Osborn, M, Ziprin, P, Cleator, S
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008609/
https://www.ncbi.nlm.nih.gov/pubmed/21063399
http://dx.doi.org/10.1038/sj.bjc.6605984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3008609/
https://www.ncbi.nlm.nih.gov/pubmed/21063399
http://dx.doi.org/10.1038/sj.bjc.6605984

Ejemplares similares